Recipient Title Director, Radiopharmaceutical Facility, 185 Berry St. Ste. 350 San Francisco , CA 94107-9107 United StatesFEI 3005947301Issued Apr 13, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3005947301.
Violations2
Issue DateApr 13, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
UCSF Radiopharmaceutical Facility
Location
Recipient Title Director, Radiopharmaceutical Facility, 185 Berry St. Ste. 350 San Francisco , CA 94107-9107 United States
FEI Number
3005947301
Country
United States
Issue Date
April 13, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
UCSF Radiopharmaceutical Facility FDA Warning Letter, April 13, 2026
Talk to a Specialist